Pantera LUX
Drug eluting ballon
Indicated for in-stent restenosis, de-novo lesions, small vessels and acute occlusions. This clinically proven solution expands treatment options. Pantera Lux, with the highly biocompatible adjuvant BHTC, effectively delivers the antiprofiling drug to the lesion site – without leaving an implant.
Highly biocompatible excipient BTHC for safe results
Pantera LUX coating technology combines paclitaxel with BTHC, a rapidly metallised, safe and biocompatible excipient 4, thus improving bioavailability. The homogeneous coating ensures proper treatment of the formulation throughout the area affected by the expanded balloon, thus minimizing geographical loss.
Pantera LUX
Drug eluting ballon
Indicated for in-stent restenosis, de-novo lesions, small vessels and acute occlusions. This clinically proven solution expands treatment options. Pantera Lux, with the highly biocompatible adjuvant BHTC, effectively delivers the antiprofiling drug to the lesion site – without leaving an implant.
Highly biocompatible excipient BTHC for safe results
Pantera LUX coating technology combines paclitaxel with BTHC, a rapidly metallised, safe and biocompatible excipient 4, thus improving bioavailability. The homogeneous coating ensures proper treatment of the formulation throughout the area affected by the expanded balloon, thus minimizing geographical loss.
Clinically proven solution for in-stent restenosis and de novo lesions
Lux coating technology for rapid drug absorption
Advanced trackability
Clinically proven solution for in-stent restenosis and de novo lesions
Lux coating technology for rapid drug absorption
Advanced trackability
Technical data
Drug Coated Balloon Catheter | |
---|---|
Catheter type | Fast-exchange PTCA balloon catheter |
Recommended guide catheter | 5F (min. I.D. 0.056”) |
Lesion entry profile | 0.017” |
Guide wire diameter | 0.014” |
Usable catheter length | 140 cm |
Balloon folding | 3-fold |
Ballon markers | Two embedded platinum-iridium markers |
Brachial shaft marker | 92 cm from tip |
Femoral shaft marker | 102 cm from tip |
Proximal shaft diameter | 2.0F |
Distal shaft diameter | 2.5F (ø 2.0 – 3.5 mm), 2.6F (ø 4.0 mm) |
Nominal pressure (NP) | 7 atm |
Rated burst pressure (RBP) | 13 atm (ø 2.0 – 3.5 mm); 12 atm (ø 4.0 mm) |
Coating | |
---|---|
Drug | Paclitaxel |
Drug dose | 3.0 μg/mm |
Delivery matrix | Paclitaxel and Butyryl-tri-hexyl citrate (BTHC) |
Coated area | Cylindrical section of the balloon, exceeding the proximal and distal markers |
Technical data
Drug Coated Balloon Catheter | |
---|---|
Catheter type | Fast-exchange PTCA balloon catheter |
Recommended guide catheter | 5F (min. I.D. 0.056”) |
Lesion entry profile | 0.017” |
Guide wire diameter | 0.014” |
Usable catheter length | 140 cm |
Balloon folding | 3-fold |
Ballon markers | Two embedded platinum-iridium markers |
Brachial shaft marker | 92 cm from tip |
Femoral shaft marker | 102 cm from tip |
Proximal shaft diameter | 2.0F |
Distal shaft diameter | 2.5F (ø 2.0 – 3.5 mm), 2.6F (ø 4.0 mm) |
Nominal pressure (NP) | 7 atm |
Rated burst pressure (RBP) | 13 atm (ø 2.0 – 3.5 mm); 12 atm (ø 4.0 mm) |
Coating | |
---|---|
Drug | Paclitaxel |
Drug dose | 3.0 μg/mm |
Delivery matrix | Paclitaxel and Butyryl-tri-hexyl citrate (BTHC) |
Coated area | Cylindrical section of the balloon, exceeding the proximal and distal markers |
Compliance Chart
| Balloon Diameter x Length (mm) | |||||
ø 2.0 x 10-30 | ø 2.5 x 10-30 | ø 3.0 x 10-30 | ø 3.5 x 10-30 | ø 4.0 x 10-30 | ||
Nominal Pressure (NP) | atm | 7 | 7 | 7 | 7 | 7 |
ø (mm) | 2.0 | 2.5 | 3.0 | 3.50 | 4 | |
Rated Burst Pressure (RBP) | atm | 13 | 13 | 13 | 13 | 12 |
ø (mm) | 2.26 | 2.82 | 3.48 | 4.11 | 4.59 |
Compliance Chart
| Balloon Diameter x Length (mm) | |||||
ø 2.0 x 10-30 | ø 2.5 x 10-30 | ø 3.0 x 10-30 | ø 3.5 x 10-30 | ø 4.0 x 10-30 | ||
Nominal Pressure (NP) | atm | 7 | 7 | 7 | 7 | 7 |
ø (mm) | 2.0 | 2.5 | 3.0 | 3.50 | 4 | |
Rated Burst Pressure (RBP) | atm | 13 | 13 | 13 | 13 | 12 |
ø (mm) | 2.26 | 2.82 | 3.48 | 4.11 | 4.59 |